skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Bardia, Aditya ; Hurvitz, Sara A ; Tolaney, Sara M ; Loirat, Delphine ; Punie, Kevin ; Oliveira, Mafalda ; Brufsky, Adam ; Sardesai, Sagar D ; Kalinsky, Kevin ; Zelnak, Amelia B ; Weaver, Robert ; Traina, Tiffany ; Dalenc, Florence ; Aftimos, Philippe ; Lynce, Filipa ; Diab, Sami ; Cortés, Javier ; O’Shaughnessy, Joyce ; Diéras, Véronique ; Ferrario, Cristiano ; Schmid, Peter ; Carey, Lisa A ; Gianni, Luca ; Piccart, Martine J ; Loibl, Sibylle ; Goldenberg, David M ; Hong, Quan ; Olivo, Martin S ; Itri, Loretta M ; Rugo, Hope S

The New England journal of medicine, 2021-04, Vol.384 (16), p.1529-1541 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Impact of Cancer‐Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
Impact of Cancer‐Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of Cancer‐Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

Curt, Gregory A. ; Breitbart, William ; Cella, David ; Groopman, Jerome E. ; Horning, Sandra J. ; Itri, Loretta M. ; Johnson, David H. ; Miaskowski, Christine ; Scherr, Susan L. ; Portenoy, Russell K. ; Vogelzang, Nicholas J.

The oncologist (Dayton, Ohio), 2000-10, Vol.5 (5), p.353-360 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por
3
5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
Material Type:
Artigo 		Adicionar ao Meu Espaço

5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen

O'BRIEN, Susan ; MOORE, Joseph O ; RAI, Kanti R ; BOYD, Thomas E ; LARRATT, Loree M ; SKOTNICKI, Aleksander B ; KOZINER, Benjamin ; CHANAN-KHAN, Asher A ; SEYMOUR, John F ; GRIBBEN, John ; ITRI, Loretta M

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5208-5212 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
Material Type:
Artigo 		Adicionar ao Meu Espaço

Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals

Klingler, Jéromine ; Lambert, Gregory S ; Itri, Vincenza ; Liu, Sean ; Bandres, Juan C ; Enyindah-Asonye, Gospel ; Liu, Xiaomei ; Simon, Viviana ; Gleason, Charles R ; Kleiner, Giulio ; Chiu, Hsin-Ping ; Hung, Chuan-Tien ; Kowdle, Shreyas ; Amanat, Fatima ; Lee, Benhur ; Zolla-Pazner, Susan ; Upadhyay, Chitra ; Hioe, Catarina E

Frontiers in immunology, 2021-12, Vol.12, p.759688-759688 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por
5
Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study
Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study

Maldonado, M. D. ; Batchala, P. ; Ornan, D. ; Fadul, C. ; Schiff, D. ; Itri, J. N. ; Jain, R. ; Patel, S. H.

Journal of neuro-oncology, 2018-10, Vol.140 (1), p.107-113 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
6
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

Warrell, Raymond P ; Frankel, Stanley R ; Miller, Wilson H ; Scheinberg, David A ; Itri, Loretta M ; Hittelman, Walter N ; Vyas, Rohini ; Andreeff, Michael ; Tafuri, Agostino ; Jakubowski, Ann ; Gabrilove, Janice ; Gordon, Michael S ; Dmitrovsky, Ethan

The New England journal of medicine, 1991-05, Vol.324 (20), p.1385-1393 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck

Hong, Waun KI ; Lippman, Scott M ; Itri, Loretta M ; Karp, Daniel D ; Lee, Jin S ; Byers, Robert M ; Schantz, Stimson P ; Kramer, Alan M ; Lotan, Reuben ; Peters, Lester J ; Dimery, Isaiah W ; Brown, Barry W ; Goepfert, Helmuth

The New England journal of medicine, 1990-09, Vol.323 (12), p.795-801 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Treatment of Hairy Cell Leukemia With Recombinant α-Interferon
Treatment of Hairy Cell Leukemia With Recombinant α-Interferon
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of Hairy Cell Leukemia With Recombinant α-Interferon

Quesada, Jorge R. ; Hersh, Evan M. ; Manning, John ; Reuben, James ; Keating, Michael ; Schnipper, Edward ; Itri, Loretta ; Gutterman, Jordan U.

Blood, 1986-08, Vol.68 (2), p.493-497 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Nevoid basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Case report
Nevoid basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Case report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nevoid basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Case report

Fini, G ; Belli, E ; Mici, E ; Virciglio, P ; Moricca, L M ; D'Itri, L ; Leonardi, A ; Malavenda, M S ; Krizzuk, D ; Merola, R ; Maturo, A ; Pasta, V

Giornale di Chirurgia - Journal of Surgery, 2013-05, Vol.34 (5-6), p.176-179 [Periódico revisado por pares]

Italy: CIC Edizioni Internationali

Texto completo disponível

Citações Citado por
10
The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: A randomized pilot study
The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: A randomized pilot study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: A randomized pilot study

Bell, Richard ; Hong, Waun Ki ; Itri, Loretta M. ; McDonald, Graeme ; Stuart Strong, M.

American journal of otolaryngology, 1988-07, Vol.9 (4), p.161-164 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (14)

Data de Publicação 

De até
Refinar
  1. Antes de1983  (3)
  2. 1983Até1987  (3)
  3. 1988Até1990  (2)
  4. 1991Até2009  (4)
  5. Após 2009  (4)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.